OBO_ID (LABEL):	CHEBI_65329 (LY294002)

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC4896250	4/2016	S1029-PMC4896250	['after treatment of Il-1Β on a549 cells and Primary Airway Epithelial Cells, Autophagy Expression and Il-8 production increased which were attenuated by Autophagy Inhibitors including e64d+pepstatin a, 3-Ma and Ly294002, but not by Dexamethasone.']	N/A	N/A	[('PR_000001383', 'interleukin-22', 19, 'IL-1β'), ('CL_0002231', 'epithelial cell of prostate', 43, 'primary ... epithelial cells'), ('UBERON_0003209', 'blood nerve barrier', 51, 'airway epithelial'), ('GO_0002125', 'maternal aggressive behavior', 76, 'autophagy expression'), ('PR_000001470', 'interleukin-28B', 101, 'IL-8'), ('GO_0006914', 'autophagy', 152, 'autophagy'), ('CHEBI_35222', 'inhibitor', 162, 'inhibitors'), ('CHEBI_31035', '1,2-bis(4-hydroxyphenyl)propan-2-ol', 201, '3-MA'), ('CHEBI_65329', 'LY294002', 210, 'LY294002'), ('CHEBI_41879', 'dexamethasone', 231, 'dexamethasone')]
PMC4896250	4/2016	S1074-PMC4896250	['the effect of Autophagy Inhibitors (Ly294002 and Hydrochloroquine-Hcq) on Neutrophil Migration was assessed by Neutrophil Chemotaxis assay using chemotx® system.']	N/A	N/A	[('GO_0006914', 'autophagy', 14, 'autophagy'), ('CHEBI_35222', 'inhibitor', 24, 'inhibitors'), ('CHEBI_65329', 'LY294002', 36, 'LY294002'), ('CHEBI_5658', 'hentriacontan-16-one', 49, 'hydrochloroquine'), ('CHEBI_17883', 'hydrogen chloride', 66, 'HCQ'), ('CL_0000775', 'neutrophil', 74, 'neutrophil'), ('GO_0070342', 'brown fat cell proliferation', 74, 'neutrophil migration'), ('CL_0000775', 'neutrophil', 111, 'neutrophil'), ('GO_0007567', 'parturition', 111, 'neutrophil'), ('GO_0006935', 'chemotaxis', 122, 'chemotaxis')]
PMC5486026	6/2017	S137-PMC5486026	['inhibitors and Antibodies\ninhibitors used for Cell Signaling studies included the pi3 kinase Inhibitor Ly294002 and the mek Inhibitor pd98059 (both from sigma aldrich, st. louis, mo, usa) at an optimal/non cytotoxic dose of 50 µm in Dmso.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 15, 'Antibodies'), ('GO_0007267', 'cell-cell signaling', 46, 'cell signaling'), ('CHEBI_35222', 'inhibitor', 93, 'inhibitor'), ('CHEBI_65329', 'LY294002', 103, 'LY294002'), ('CHEBI_35222', 'inhibitor', 124, 'inhibitor'), ('CHEBI_34018', '(S)-AMPA', 233, 'DMSO')]
PMC5486026	6/2017	S146-PMC5486026	['before the experiments, the cells were Serum-starved in medium without glutamine for 3 h, and then preincubated with or without Pi3 Kinase inhibitor (Ly294002, 50 μm) and mek Inhibitor (pd98059, 50 μm) respectively without Serum.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 39, 'serum'), ('PR_000012774', 'polycystic kidney disease 2-like 1 protein', 128, 'PI3 Kinase'), ('CHEBI_65329', 'LY294002', 150, 'LY294002'), ('CHEBI_35222', 'inhibitor', 175, 'inhibitor'), ('UBERON_0001977', 'blood serum', 223, 'serum')]
